These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 30252602)

  • 1. Prediction of methionine oxidation risk in monoclonal antibodies using a machine learning method.
    Sankar K; Hoi KH; Yin Y; Ramachandran P; Andersen N; Hilderbrand A; McDonald P; Spiess C; Zhang Q
    MAbs; 2018; 10(8):1281-1290. PubMed ID: 30252602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Tryptophan Oxidation in Complementarity-Determining Regions of Two Monoclonal Antibodies on Structure-Function Characterized by Hydrogen-Deuterium Exchange Mass Spectrometry and Surface Plasmon Resonance.
    Hageman T; Wei H; Kuehne P; Fu J; Ludwig R; Tao L; Leone A; Zocher M; Das TK
    Pharm Res; 2018 Dec; 36(1):24. PubMed ID: 30536043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isomerization and Oxidation in the Complementarity-Determining Regions of a Monoclonal Antibody: A Study of the Modification-Structure-Function Correlations by Hydrogen-Deuterium Exchange Mass Spectrometry.
    Yan Y; Wei H; Fu Y; Jusuf S; Zeng M; Ludwig R; Krystek SR; Chen G; Tao L; Das TK
    Anal Chem; 2016 Feb; 88(4):2041-50. PubMed ID: 26824491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel method for in silico assessment of Methionine oxidation risk in monoclonal antibodies: Improvement over the 2-shell model.
    Tavella D; Ouellette DR; Garofalo R; Zhu K; Xu J; Oloo EO; Negron C; Ihnat PM
    PLoS One; 2022; 17(12):e0279689. PubMed ID: 36580468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of the Hydrogen Peroxide-Induced Methionine Oxidation Propensity in Monoclonal Antibodies.
    Agrawal NJ; Dykstra A; Yang J; Yue H; Nguyen X; Kolvenbach C; Angell N
    J Pharm Sci; 2018 May; 107(5):1282-1289. PubMed ID: 29325924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidation in the complementarity-determining regions differentially influences the properties of therapeutic antibodies.
    Dashivets T; Stracke J; Dengl S; Knaupp A; Pollmann J; Buchner J; Schlothauer T
    MAbs; 2016; 8(8):1525-1535. PubMed ID: 27612038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitigation of Oxidation in Therapeutic Antibody Formulations: a Biochemical Efficacy and Safety Evaluation of N-Acetyl-Tryptophan and L-Methionine.
    Dion MZ; Leiske D; Sharma VK; Zuch de Zafra CL; Salisbury CM
    Pharm Res; 2018 Oct; 35(11):222. PubMed ID: 30280329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homology modeling and structure-based design improve hydrophobic interaction chromatography behavior of integrin binding antibodies.
    Jetha A; Thorsteinson N; Jmeian Y; Jeganathan A; Giblin P; Fransson J
    MAbs; 2018; 10(6):890-900. PubMed ID: 30110240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the Impact of Methionine Oxidation on the Biological Functions of IgG1 Antibodies Using Hydrogen/Deuterium Exchange Mass Spectrometry.
    Mo J; Yan Q; So CK; Soden T; Lewis MJ; Hu P
    Anal Chem; 2016 Oct; 88(19):9495-9502. PubMed ID: 27575380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic Modeling of Methionine Oxidation in Monoclonal Antibodies from Hydrogen Peroxide Spiking Studies.
    Hui A; Lam XM; Kuehl C; Grauschopf U; Wang YJ
    PDA J Pharm Sci Technol; 2015; 69(4):511-25. PubMed ID: 26242787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A competitive binding-mass spectrometry strategy for high-throughput evaluation of potential critical quality attributes of therapeutic monoclonal antibodies.
    Zhang Z; Yan Y; Wang S; Li N
    MAbs; 2022; 14(1):2133674. PubMed ID: 36224723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Characterization of Two Monoclonal Antibodies against the Same Epitope on B-Cell Receptor Associated Protein 31.
    Kim WT; Shin S; Hwang HJ; Kim MK; Jung HS; Park H; Ryu CJ
    PLoS One; 2016; 11(12):e0167527. PubMed ID: 27907150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid assessment of oxidation via middle-down LCMS correlates with methionine side-chain solvent-accessible surface area for 121 clinical stage monoclonal antibodies.
    Yang R; Jain T; Lynaugh H; Nobrega RP; Lu X; Boland T; Burnina I; Sun T; Caffry I; Brown M; Zhi X; Lilov A; Xu Y
    MAbs; 2017; 9(4):646-653. PubMed ID: 28281887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-Resolution IMS-MS to Assign Additional Disulfide Bridge Pairing in Complementarity-Determining Regions of an IgG4 Monoclonal Antibody.
    Deslignière E; Botzanowski T; Diemer H; Cooper-Shepherd DA; Wagner-Rousset E; Colas O; Béchade G; Giles K; Hernandez-Alba O; Beck A; Cianférani S
    J Am Soc Mass Spectrom; 2021 Oct; 32(10):2505-2512. PubMed ID: 34437803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physicochemical and biological impact of metal-catalyzed oxidation of IgG1 monoclonal antibodies and antibody-drug conjugates via reactive oxygen species.
    Glover ZK; Wecksler A; Aryal B; Mehta S; Pegues M; Chan W; Lehtimaki M; Luo A; Sreedhara A; Rao VA
    MAbs; 2022; 14(1):2122957. PubMed ID: 36151884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of methionine oxidation in thermal stability and chemically stressed samples of a fully human monoclonal antibody.
    Chumsae C; Gaza-Bulseco G; Sun J; Liu H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 850(1-2):285-94. PubMed ID: 17182291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery and Control of Succinimide Formation and Accumulation at Aspartic Acid Residues in The Complementarity-Determining Region of a Therapeutic Monoclonal Antibody.
    VanAernum ZL; Sergi JA; Dey M; Toner T; Kilgore B; Lay-Fortenbery A; Wang Y; Bian S; Kochert BA; Bothe JR; Gao X; Richardson D; Schuessler HA
    Pharm Res; 2023 Jun; 40(6):1411-1423. PubMed ID: 36627449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico prediction of post-translational modifications in therapeutic antibodies.
    Vatsa S
    MAbs; 2022; 14(1):2023938. PubMed ID: 35040751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Qualification of a Quantitative Method for Monitoring Aspartate Isomerization of a Monoclonal Antibody by Focused Peptide Mapping.
    Cao M; Mo WD; Shannon A; Wei Z; Washabaugh M; Cash P
    PDA J Pharm Sci Technol; 2016 11/12; 70(6):490-507. PubMed ID: 27091886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analytical protein a chromatography as a quantitative tool for the screening of methionine oxidation in monoclonal antibodies.
    Loew C; Knoblich C; Fichtl J; Alt N; Diepold K; Bulau P; Goldbach P; Adler M; Mahler HC; Grauschopf U
    J Pharm Sci; 2012 Nov; 101(11):4248-57. PubMed ID: 22899501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.